| PRECLINICAL | evidence | Characterization of the Protein Components of Matrix Stones Sheds Light on S100-A8 and S100-A9 Relevance in the Inflammatory Pathogenesis of These Rare Renal Calculi. | Thymosin beta 4 | Inflammation | 2016-09-01 |
| PRECLINICAL | evidence | Serum Thymosin beta4 Concentrations in Obstructive Sleep Apnea Syndrome Patients. | Thymosin beta 4 | Sleep quality | 2016-09-01 |
| PRECLINICAL | evidence | Thymosin beta 4 silencing suppresses proliferation and invasion of non-small cell lung cancer cells by repressing Notch1 activation. | Tbeta4 | — | 2016-09-01 |
| PRECLINICAL | evidence | Solid-phase extraction of small biologically active peptides on cartridges and microelution 96-well plates from human urine. | TB 500 | — | 2016-09-01 |
| PRECLINICAL | evidence | A peptide from human beta thymosin as a platform for the development of new anti-biofilm agents for Staphylococcus spp. and Pseudomonas aeruginosa. | Thymosin beta 4 | — | 2016-08-01 |
| PRECLINICAL | evidence | Role of thymosin beta 4 in hair growth. | Tbeta4 | — | 2016-08-01 |
| PRECLINICAL | evidence | Thymosin beta4 Prevents Angiotensin II-Induced Cardiomyocyte Growth by Regulating Wnt/WISP Signaling. | Tbeta4 | — | 2016-08-01 |
| PRECLINICAL | evidence | Development of the intein-mediated method for production of recombinant thymosin beta4 from the acetylated in vivo fusion protein. | Tbeta4 | — | 2016-06-20 |
| PRECLINICAL | evidence | Thymosin beta4 impeded murine stem cell proliferation with an intact cardiovascular differentiation. | Tbeta4 | — | 2016-06-01 |
| PRECLINICAL | evidence | The Dendritic Cell Major Histocompatibility Complex II (MHC II) Peptidome Derives from a Variety of Processing Pathways and Includes Peptides with a Broad Spectrum of HLA-DM Sensitivity. | Thymosin beta 4 | — | 2016-03-11 |
| PRECLINICAL | evidence | Effect of Thymosin beta4 on the Differentiation and Mineralization of MC3T3-E1 Cell on a Titanium Surface. | Tbeta4 | — | 2016-02-01 |
| PRECLINICAL | evidence | Immunohistochemical markers of neural progenitor cells in the early embryonic human cerebral cortex. | Tbeta4 | — | 2016-02-01 |
| PRECLINICAL | evidence | Thymosin beta4 induces proliferation, invasion, and epithelial-to-mesenchymal transition of oral squamous cell carcinoma. | Tbeta4 | — | 2016-01-01 |
| PRECLINICAL | evidence | Thymosin beta4 Promotes Dermal Healing. | Tbeta4 | Wound healing | 2016-01-01 |
| PRECLINICAL | evidence | Plasma levels of F-actin and F:G-actin ratio as potential new biomarkers in patients with septic shock. | Thymosin beta 4 | — | 2016-01-01 |
| PRECLINICAL | evidence | The effects of advanced glycation end products (AGEs) on dermal wound healing and scar formation: a systematic review. | Thymosin β4 | — | 2016-01-01 |
| PRECLINICAL | evidence | Intrinsic, Functional, and Structural Properties of beta-Thymosins and beta-Thymosin/WH2 Domains in the Regulation and Coordination of Actin Self-Assembly Dynamics and Cytoskeleton Remodeling. | Thymosin β4 | Immune function | 2016-01-01 |
| PRECLINICAL | evidence | Association of thymosin beta4 expression with clinicopathological parameters and clinical outcomes of bladder cancer patients. | Tbeta4 | — | 2016-01-01 |
| PRECLINICAL | evidence | Systemic Dosing of Thymosin Beta 4 before and after Ischemia Does Not Attenuate Global Myocardial Ischemia-Reperfusion Injury in Pigs. | Thymosin beta 4 | — | 2016-01-01 |
| PRECLINICAL | evidence | A Tobacco-Derived Thymosin beta4 Concatemer Promotes Cell Proliferation and Wound Healing in Mice. | Tbeta4 | Wound healing | 2016-01-01 |
| PRECLINICAL | evidence | Thymosin Beta 4: A Potential Novel Therapy for Neurotrophic Keratopathy, Dry Eye, and Ocular Surface Diseases. | Tbeta4 | — | 2016-01-01 |
| PRECLINICAL | evidence | Thymosin beta4: Roles in Development, Repair, and Engineering of the Cardiovascular System. | Tbeta4 | Lipid & cardiovascular markers | 2016-01-01 |
| PRECLINICAL | evidence | Cardioprotection by Thymosin Beta 4. | Tbeta4 | — | 2016-01-01 |
| PRECLINICAL | evidence | Actin-Induced Structure in the Beta-Thymosin Family of Intrinsically Disordered Proteins. | Tbeta4 | — | 2016-01-01 |
| PRECLINICAL | evidence | Structures of Thymosin Proteins. | Thymosin beta 4 | — | 2016-01-01 |
| PRECLINICAL | evidence | Systemic Dosing of Thymosin Beta 4 before and after Ischemia Does Not Attenuate Global Myocardial Ischemia-Reperfusion Injury in Pigs. | TB4 | — | 2016-01-01 |
| PRECLINICAL | evidence | Function of Thymosin Beta-4 in Ethanol-Induced Microglial Activation. | Tbeta4 | Inflammation | 2016-01-01 |
| PRECLINICAL | evidence | Thymosin Beta 4 Is a Potential Regulator of Hepatic Stellate Cells. | Tbeta4 | Liver health | 2016-01-01 |
| PRECLINICAL | evidence | Thymosin Beta-4 Suppresses Osteoclastic Differentiation and Inflammatory Responses in Human Periodontal Ligament Cells. | Tbeta4 | Inflammation | 2016-01-01 |
| PRECLINICAL | evidence | Plasma levels of F-actin and F:G-actin ratio as potential new biomarkers in patients with septic shock. | TB4 | Inflammation | 2016-01-01 |
| PRECLINICAL | evidence | Simplifying and expanding the screening for peptides <2 kDa by direct urine injection, liquid chromatography, and ion mobility mass spectrometry. | TB 500 | — | 2016-01-01 |
| PRECLINICAL | evidence | TMSB4Y is a candidate tumor suppressor on the Y chromosome and is deleted in male breast cancer. | Thymosin beta 4 | preclinical | 2015-12-29 |
| PRECLINICAL | evidence | MALDI-imaging reveals thymosin beta-4 as an independent prognostic marker for colorectal cancer. | Tbeta4 | — | 2015-12-22 |
| PRECLINICAL | evidence | Peptide fragment of thymosin beta4 increases hippocampal neurogenesis and facilitates spatial memory. | TB4 | — | 2015-12-03 |
| PRECLINICAL | evidence | Peptide fragment of thymosin beta4 increases hippocampal neurogenesis and facilitates spatial memory. | Thymosin beta 4 | — | 2015-12-03 |
| PRECLINICAL | evidence | Thymosin beta4 inhibits microglia activation through microRNA 146a in neonatal rats following hypoxia injury. | Tbeta4 | Inflammation | 2015-12-02 |
| PRECLINICAL | evidence | Effects of thymosin beta4 on a rat model of severe acute pancreatitis. | Thymosin β4 | — | 2015-12-01 |
| PRECLINICAL | evidence | C-terminal variable AGES domain of Thymosin beta4: the molecule's primary contribution in support of post-ischemic cardiac function and repair. | Thymosin beta 4 | — | 2015-10-01 |
| PRECLINICAL | evidence | C-terminal variable AGES domain of Thymosin beta4: the molecule's primary contribution in support of post-ischemic cardiac function and repair. | TB4 | — | 2015-10-01 |
| PRECLINICAL | evidence | The Effect of Thymosin beta4 for Osteoblast Adhesion on Titanium Surface. | Tbeta4 | — | 2015-08-01 |
| PRECLINICAL | evidence | Thymosin-beta4 is a determinant of drug sensitivity for Fenretinide and Vorinostat combination therapy in neuroblastoma. | Tbeta4 | preclinical | 2015-08-01 |
| PRECLINICAL | evidence | Primary Mechanisms of Thymosin beta4 Repair Activity in Dry Eye Disorders and Other Tissue Injuries. | Tbeta4 | Wound healing | 2015-08-01 |
| PRECLINICAL | evidence | A microfibril assembly assay identifies different mechanisms of dominance underlying Marfan syndrome, stiff skin syndrome and acromelic dysplasias. | TB4 | — | 2015-08-01 |
| PRECLINICAL | evidence | Thymosin beta4 promotes hepatoblastoma metastasis via the induction of epithelial-mesenchymal transition. | Tbeta4 | — | 2015-07-01 |
| PRECLINICAL | evidence | Expression of thymosin beta-4 in human periodontal ligament cells and mouse periodontal tissue and its role in osteoblastic/cementoblastic differentiation. | Tbeta4 | Tendon & ligament repair | 2015-07-01 |
| PRECLINICAL | evidence | Thymosin Beta-4 Recombinant Adeno-associated Virus Enhances Human Nucleus Pulposus Cell Proliferation and Reduces Cell Apoptosis and Senescence. | TB4 | Longevity & cellular aging · preclinical | 2015-06-05 |
| PRECLINICAL | evidence | Thymosin Beta-4 Recombinant Adeno-associated Virus Enhances Human Nucleus Pulposus Cell Proliferation and Reduces Cell Apoptosis and Senescence. | Thymosin beta 4 | preclinical | 2015-06-05 |
| PRECLINICAL | evidence | Potential role of thymosin Beta 4 in liver fibrosis. | Tbeta4 | Liver health | 2015-05-08 |
| PRECLINICAL | evidence | Thymosin beta 4 is associated with RUNX2 expression through the Smad and Akt signaling pathways in mouse dental epithelial cells. | TB4 | — | 2015-05-01 |
| PRECLINICAL | evidence | Prolonging nephrogenesis in preterm infants: a new approach for prevention of kidney disease in adulthood? | Thymosin beta 4 | Longevity & cellular aging | 2015-05-01 |